BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37560212)

  • 1. A novel prognostic scoring system to predict portal vein tumor thrombosis in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Li M; Dang Z; Ma S; Wang Y; Xu X; Li B; Qian P; Dang Z
    Am J Transl Res; 2023; 15(7):4600-4609. PubMed ID: 37560212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Eastern Hepatobiliary Surgery Hospital/Portal Vein Tumor Thrombus Scoring System as an Aid to Decision Making on Hepatectomy for Hepatocellular Carcinoma Patients With Portal Vein Tumor Thrombus: A Multicenter Study.
    Zhang XP; Gao YZ; Chen ZH; Chen MS; Li LQ; Wen TF; Xu L; Wang K; Chai ZT; Guo WX; Shi J; Xie D; Wu MC; Yee Lau W; Cheng SQ
    Hepatology; 2019 May; 69(5):2076-2090. PubMed ID: 30586158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early risk warning system for distant metastasis of hepatitis B virus-associated hepatocellular carcinoma with portal vein tumor thrombus.
    Li M; Zhao Y; Liu X; Zhang S; Jiang Y; Yang Z
    Oncol Lett; 2020 Apr; 19(4):3249-3257. PubMed ID: 32256820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The correlations between hepatitis B virus infection and hepatocellular carcinoma with portal vein tumor thrombus or extrahepatic metastasis.
    Chen J; Shi X; Luo T; Zhao Y; Ye J; Bai T; Li L
    Eur J Gastroenterol Hepatol; 2020 Mar; 32(3):373-377. PubMed ID: 31441795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection.
    Fu YP; Yi Y; Huang JL; Jing CY; Sun J; Ni XC; Lu ZF; Cao Y; Zhou J; Fan J; Qiu SJ
    Oncologist; 2017 May; 22(5):561-569. PubMed ID: 28438885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of the clinical profile, predictors, prognostic features, and survival of patients with hepatocellular carcinoma having macroscopic portal vein tumor thrombosis.
    Jearth V; Patil PS; Mehta S; Goel M; Patkar S; Kulkarni S; Shetty N; Ostwal V; Ramaswamy A; Sastri S; Engineer R
    Indian J Gastroenterol; 2022 Dec; 41(6):533-543. PubMed ID: 36715840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion.
    Spreafico C; Sposito C; Vaiani M; Cascella T; Bhoori S; Morosi C; Lanocita R; Romito R; Chiesa C; Maccauro M; Marchianò A; Mazzaferro V
    J Hepatol; 2018 Apr; 68(4):724-732. PubMed ID: 29331342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative prediction of hepatocellular carcinoma with portal vein tumor thrombus based on conventional data.
    Zhu P; Liao Y; Fan J; Li X; Su L; Li J; Yuan S; Yu J; Liao W
    Oncotarget; 2017 Nov; 8(61):104227-104237. PubMed ID: 29262635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nomogram to predict early postoperative recurrence of hepatocellular carcinoma with portal vein tumour thrombus after R0 liver resection: A large-scale, multicenter study.
    Zhang XP; Chen ZH; Zhou TF; Li LQ; Chen MS; Wen TF; Shi J; Guo WX; Wu MC; Lau WY; Cheng SQ;
    Eur J Surg Oncol; 2019 Sep; 45(9):1644-1651. PubMed ID: 30982657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus infection and active replication promote the formation of vascular invasion in hepatocellular carcinoma.
    Wei X; Li N; Li S; Shi J; Guo W; Zheng Y; Cheng S
    BMC Cancer; 2017 May; 17(1):304. PubMed ID: 28464845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical outcome and risk scoring to predict survival after hepatic resection for hepatocellular carcinoma with portal vein tumor thrombosis.
    Kim TS; Yang K; Choi GH; Yang HY; Kim DS; Jo HS; Choi GS; Kim KW; Yoon YC; Han J; Kim DJ; Hwang S; Kang KJ
    Ann Hepatobiliary Pancreat Surg; 2024 May; 28(2):134-143. PubMed ID: 38720612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis.
    Lee JM; Jang BK; Lee YJ; Choi WY; Choi SM; Chung WJ; Hwang JS; Kang KJ; Kim YH; Chauhan AK; Park SY; Tak WY; Kweon YO; Kim BS; Lee CH
    Clin Mol Hepatol; 2016 Mar; 22(1):160-7. PubMed ID: 27044767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors of microvascular invasion, portal vein tumor thrombosis and poor post-resectional survival in HBV-related hepatocellular carcinoma.
    Zhou L; Rui JA; Wang SB; Chen SG; Qu Q
    Hepatogastroenterology; 2014 Sep; 61(134):1696-703. PubMed ID: 25436365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new and rare type of hepatocellular carcinoma: Survival and gene analysis of portal vein tumour thrombus-type hepatocellular carcinoma.
    Guo WX; Yang SY; Guo L; Feng JK; Xue J; Shi J; Lau WY; Yu D; Cheng SQ
    Pathol Res Pract; 2023 Jan; 241():154260. PubMed ID: 36509007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apatinib Combined With Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombus: A Multicenter Retrospective Study.
    Fan W; Yuan G; Fan H; Li F; Wu Y; Zhao Y; Yao W; Wang Y; Xue M; Yang J; Li J
    Clin Ther; 2019 Aug; 41(8):1463-1476. PubMed ID: 31303279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis].
    Luo J; Zheng JP; Shao GL; Wen S; Guo LW; Zeng H; Zhang L; Qian CY; Hao WY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):298-304. PubMed ID: 29996343
    [No Abstract]   [Full Text] [Related]  

  • 17. Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus: 2016 edition.
    Cheng S; Chen M; Cai J;
    Oncotarget; 2017 Jan; 8(5):8867-8876. PubMed ID: 27780939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prognostic Comparison Between Hepatocellular Carcinoma with Portal Vein Tumor Thrombus and Bile Duct Cancer Thrombus After Liver Resection.
    Yang X; Zhu Y; Zhao X; Li JH; Xu D; Jia HL; Zhang JB
    Cancer Manag Res; 2020; 12():12077-12086. PubMed ID: 33262656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of hepatocellular carcinoma with portal vein tumor thrombus:assessment based on clinical and computer tomography characteristics.
    Jia L; Kiryu S; Watadani T; Akai H; Yamashita H; Akahane M; Ohtomo K
    Acta Med Okayama; 2012; 66(2):131-41. PubMed ID: 22525471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment Non-Invasive Biomarkers as Predictors to Estimate Portal Vein Tumor Thrombosis (PVTT) Risk and Long-Term Survival in HBV-Related Hepatocellular Carcinoma Patients Without PVTT.
    Liu B; Liu J; Mei X; Zhang ZQ; Fang J; Zhou LL; Zheng JL; Lin HY; Zhu XL; Li DL
    J Hepatocell Carcinoma; 2023; 10():2367-2382. PubMed ID: 38164511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.